ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 7.435
AS - Asia 4.916
EU - Europa 2.227
SA - Sud America 374
AF - Africa 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.014
Nazione #
US - Stati Uniti d'America 7.306
HK - Hong Kong 2.210
SG - Singapore 1.134
CN - Cina 760
IT - Italia 528
UA - Ucraina 497
VN - Vietnam 393
BR - Brasile 288
DE - Germania 274
RU - Federazione Russa 225
FI - Finlandia 173
FR - Francia 145
IE - Irlanda 140
TR - Turchia 88
KR - Corea 78
SE - Svezia 78
GB - Regno Unito 68
IN - India 65
MX - Messico 55
CA - Canada 50
BD - Bangladesh 32
AR - Argentina 28
IQ - Iraq 25
JP - Giappone 25
ZA - Sudafrica 22
PL - Polonia 19
CO - Colombia 17
ES - Italia 16
CZ - Repubblica Ceca 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 13
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
JO - Giordania 10
UZ - Uzbekistan 10
JM - Giamaica 9
MA - Marocco 9
NL - Olanda 8
IL - Israele 7
AT - Austria 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
KE - Kenya 5
LT - Lituania 5
RS - Serbia 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
PE - Perù 4
BY - Bielorussia 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
PY - Paraguay 3
RO - Romania 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
RE - Reunion 1
RW - Ruanda 1
Totale 15.005
Città #
Hong Kong 2.201
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 597
Singapore 577
San Jose 572
Dallas 515
Princeton 393
Ashburn 331
Houston 267
Dong Ket 210
Woodbridge 209
Beijing 150
Munich 139
Dublin 137
Council Bluffs 115
Boardman 111
Nanjing 110
Dearborn 107
The Dalles 99
Andover 97
Lauterbourg 93
Pellezzano 76
Ho Chi Minh City 70
Salerno 65
Izmir 62
Helsinki 58
Los Angeles 55
Mestre 49
Moscow 49
Fairfield 41
Hanoi 40
Redwood City 37
São Paulo 36
Nanchang 35
Hebei 33
New York 33
Shenyang 33
Changsha 27
Orem 25
Tokyo 25
Montreal 22
Tianjin 21
Jiaxing 20
Pune 20
Santa Clara 20
Warsaw 19
Chennai 16
London 16
Napoli 16
Sant'agata De' Goti 16
Washington 16
Memphis 15
Brooklyn 14
Cuauhtémoc 14
Stockholm 14
Agropoli 13
Istanbul 13
Johannesburg 13
Phoenix 13
Brno 12
Chicago 12
Manchester 12
Norwalk 12
Turku 12
Belo Horizonte 11
Cava 11
Düsseldorf 11
Frankfurt am Main 11
Guangzhou 11
Ottawa 11
San Diego 11
Seattle 11
Medellín 10
Tashkent 10
Amman 9
Da Nang 9
Lessolo 9
Poplar 9
Atlanta 8
Bologna 8
Boston 8
Denver 8
Haiphong 8
Naples 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Baghdad 7
Bari 7
Caserta 7
Jinan 7
Ankara 6
Kunming 6
Lahore 6
Marsico Nuovo 6
Mexico City 6
Rome 6
San Francisco 6
Totale 11.184
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 712
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 646
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 568
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 341
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 288
Searching for the protein targets of 4-nonylphenol using a computational approach 264
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 243
Analysis of transglutaminase protein substrates by functional proteomics. 228
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 201
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 199
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 198
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 192
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 184
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 183
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 182
Application of a computational approach to identify protein targets for 4-nonylphenol 178
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 166
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 165
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 165
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 164
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 162
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 159
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 158
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 158
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 158
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 157
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 155
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 154
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 149
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 148
Tissue transglutaminase in celiac disease: role of autoantibodies. 147
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 145
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 143
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 141
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 140
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 139
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 134
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 133
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 131
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 130
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 129
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 129
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 128
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 128
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 128
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 125
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 125
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 124
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 122
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 120
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 117
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 115
Transglutaminase 2 in celiac diasease: Minireview article 115
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 114
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 113
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 113
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 113
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 113
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 108
Tissue Transglutaminase and Coeliac Disease. 108
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 108
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 108
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 108
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 107
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 107
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 107
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 104
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 103
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 103
Effects of Methyl Bromide on activity of blood coagulation enzymes 102
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 101
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 100
null 98
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 97
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 96
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 96
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 95
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 93
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 93
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 93
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 91
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 91
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 91
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 90
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 90
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 87
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 87
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 87
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 86
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 86
Desmoplakin acts as transglutaminase substrate in vitro. 85
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 84
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 83
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 81
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 80
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 80
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 79
Identification of tissue transglutaminase protein substrates in Caco-2 cells 79
Coeliac disease and extraintestinal autoimmunity. 75
Rat prostate transglutaminase: biochemical properties of recombinant forms expressed into COS-1 cells 75
Totale 14.501
Categoria #
all - tutte 45.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 0 0 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20266.034 540 980 1.501 330 592 272 690 135 303 533 121 37
Totale 15.226